← All news
Synthetic Biology
Synthetic biology involves designing and engineering biological systems to perform new functions that don't occur in nature, often using computational tools and AI to predict how organisms will behave. In enterprise AI governance, this matters because organizations developing synthetic biology applications face distinctive risks around unintended ecological impacts, dual-use concerns (where the same technology could serve harmful purposes), and regulatory uncertainty across jurisdictions. Companies in this space need governance frameworks that address not just AI model safety, but also the downstream consequences of deploying engineered organisms or biological designs at scale.
1 item
